The following table summarizes the incidence rates of adverse events reported by at least 1% of patients who received dihydroergotamine mesylate nasal spray for the treatment of migraine headaches during placebo-controlled, double-blind clinical studies and were more frequent than in those patients receiving placebo
Hopkins Tanne J, Wegovy: FDA approves weight loss drug to cut cardiovascular risk
Both reviewers went over each study independently by their titles, abstracts, and other criteria to determine inclusion for further analysis or not as the first screening
The back surface of the teeth (palatal surface) closest to the tongue are more likely to see damage and this damage may not be obvious to the sufferer
2008;92:761794, viii
Presgera is not marketed as an auto-ship subscription product on its main retail pages, and Presgera sales are presented as one-time purchases without surprise recurring billing, with Presgera buyers commonly receiving email confirmations, shipping notifications, and customer service contact details tied to the Aurora, Colorado returns address listed in product literature